Last updated on September 2017

A Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the safety, tolerability and the pharmacokinetics (PK) of topical INCB018424 cream applied to pediatric subjects (age ≥ 12 to 17 years) with atopic dermatitis (AD).

Clinical Study Identifier: NCT03257644

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Peck Ong

Children's Hospital of Los Angeles
Los Angeles, CA United States
  Connect »

Wynnis Tom

Rady Children's Hospital - San Diego
San Diego, CA United States
  Connect »

Donald Leung

National Jewish Health
Denver, CO United States
  Connect »

Amy Paller

Northwestern University Department of Dermatology
Chicago, IL United States
  Connect »

David Fivenson

David Fivenson, MD, Dermatology, PLC
Ann Arbor, MI United States
  Connect »

Adnan Nasir

Wake Research Associates
Raleigh, NC United States
  Connect »

Andrea Zaenglein

Penn State Hershey Medical Center
Hershey, PA United States
  Connect »

John Browning

Texas Dermatology and Laser Specialist Clinical Research
San Antonio, TX United States
  Connect »